Supplement Stacking Guide: What Combines Well (and What to Avoid)

A supplement stacking guide built on actual biochemistry looks very different from one built on marketing synergy claims. This guide evaluates the most common supplement combinations using three criteria: mechanistic rationale (do the pathways interact?), clinical evidence (has the combination been tested in humans?), and safety signals (are there known interactions?). Honest answers produce a more conservative stack than most longevity content suggests — and a more defensible one.

The Evidence Base for Supplement Stacking

Stacking-specific research is sparse. Most supplement trials test single compounds, and the few combination trials that exist often use proprietary multi-ingredient formulas — making it impossible to determine which component drove any observed result. This means most synergy claims are extrapolated from single-compound mechanisms, not from directly tested combinations.

Below are evidence-informed stacking combinations, categorised by goal:

Goal	Core Stack	Add-On (Optional)	Timing	Interaction Note
Sleep & Recovery	Magnesium Glycinate 300 mg	Ashwagandha 300 mg (KSM-66)	45–60 min before bed	Additive calming effect; generally safe
NAD⁺ / Longevity	NMN 250–500 mg	Resveratrol 250 mg (SIRT1 co-activator)	Morning with meal	Resveratrol may enhance sirtuin activation
Stress & Cortisol	Ashwagandha 600 mg	Magnesium 300 mg (any absorbable form)	Morning or split dose	Both target HPA axis; well-tolerated combo
Metabolic Health	Magnesium 300 mg + NMN 250 mg	Berberine 500 mg	With meals	Monitor blood glucose if diabetic medication used
Cognitive Performance	NMN 500 mg + Magnesium Threonate	Lion's Mane 500 mg	Morning	No known adverse interactions; limited combined human data

The Gomes et al. (2013) Cell paper established the mechanistic basis for NAD+ decline in aging and informs NMN stacking rationale. The Chandrasekhar et al. (2012) trial established ashwagandha's cortisol-lowering effects. Neither paper tested combinations. When combination recommendations appear below, the evidence quality for that claim will be stated explicitly.

How Supplement Interactions Work

Supplement interactions fall into three mechanistic categories:

1. Complementary mechanisms: Two compounds act on different steps in the same pathway, producing additive or synergistic effects — for example, NMN provides NAD+ substrate while resveratrol activates SIRT1, which requires NAD+ as a cofactor.
2. Absorption interactions: One compound impairs or enhances the absorption of another — magnesium and zinc at high doses share the same intestinal transporter and compete; vitamin D requires magnesium as an enzymatic cofactor for hydroxylation to its active form.
3. Redundant mechanisms: Both compounds act on the same molecular target via the same pathway, with no additive effect — combining NMN with niacin floods the same biosynthetic route without proportional NAD+ gains.

Knowing which category a combination falls into determines whether adding the second compound is worth doing at all.

Stack 1: NMN + Resveratrol

Mechanistic rationale: Resveratrol is a SIRT1 activator — specifically, it's classified as an STAC (sirtuin-activating compound). SIRT1 is NAD+-dependent: it cannot function without adequate NAD+ as a cosubstrate. The theoretical synergy is that Bio:sudo NMN 1000mg raises cellular NAD+ while resveratrol ensures SIRT1 is activated to use that NAD+, amplifying the downstream epigenetic and metabolic effects. This framework originates largely from David Sinclair's lab at Harvard.

Human evidence: Limited as a combination. Individual human NMN trials are published (Yoshino 2021, Igarashi 2022, Irie 2020). Individual resveratrol trials exist but show inconsistent results — resveratrol has poor bioavailability in standard oral form and is rapidly metabolized. No published RCT has tested NMN + resveratrol as a combination in humans with a defined longevity or aging endpoint.

Assessment: Mechanistically sound; clinically untested as a combination. The mechanistic argument is coherent; the expected magnitude of benefit is genuinely unknown. This is a reasonable hypothesis-driven combination, not one with confirmatory human data behind it.

Stack 2: NMN + TMG (Trimethylglycine)

Mechanistic rationale: NAD+ biosynthesis via the salvage pathway consumes methyl groups — specifically, NMN's conversion involves enzymatic steps that can draw on the SAM (S-adenosylmethionine) methyl pool. TMG (betaine) is a methyl donor that replenishes SAM. The concern: high-dose NMN supplementation might create a methylation drain, reducing SAM availability for other methylation reactions (DNA methylation, neurotransmitter synthesis, homocysteine remethylation).

Human evidence: No published clinical trial on NMN + TMG in humans. Niu et al. (2023) found no concerning metabolic shifts in their 30-day NMN trial at 300 mg/day. The methylation concern comes from theoretical biochemistry and some animal work, not confirmed human deficiency data at typical supplemental doses.

Assessment: The methylation concern has mechanistic validity but limited clinical evidence at standard NMN doses. If you're taking high doses (>1000 mg/day) and want to hedge against methylation impact, TMG is low-risk and widely available. At 250–500 mg/day NMN in healthy adults, it's likely unnecessary.

Stack 3: Magnesium + Vitamin D (Strongest Evidence)

Mechanistic rationale: Magnesium is a required cofactor for the enzymes that hydroxylate vitamin D3 to 25-hydroxyvitamin D (in the liver) and subsequently to 1,25-dihydroxyvitamin D (in the kidney). Without adequate magnesium, vitamin D supplementation provides the substrate without the enzymatic cofactor — partial activation at best. Additionally, higher vitamin D intake increases magnesium requirements by upregulating magnesium-dependent enzymatic activity.

Human evidence: This interaction is well-documented in biochemistry and has observational support in humans. Schwalfenberg and Genuis (2017) reviewed the clinical implications. Population studies show that magnesium status correlates with vitamin D response variability. This is the most evidence-supported combination in this guide — not the most novel, but the most established.

Assessment: If you supplement with vitamin D, magnesium glycinate is a logical co-supplement. The evidence basis is strong enough to consider this a standard pairing rather than an experimental stack. See Ashwagandha vs Magnesium for context on where each fits in a broader protocol.

Stack 4: Ashwagandha + NMN

Mechanistic rationale: These compounds address different axes of physiological stress. Ashwagandha (KSM-66) reduces HPA axis hyperreactivity and lowers serum cortisol. NMN restores cellular NAD+ availability. The mechanistic link: chronic cortisol elevation activates CD38 — an NAD+-consuming enzyme that's also upregulated by inflammatory and oxidative stress. Reducing cortisol burden (ashwagandha) while replenishing the NAD+ that chronic HPA activation depletes (NMN) addresses two components of the same stress-aging cascade.

Human evidence: No direct combination trial exists. Each compound has independent human evidence: ashwagandha's cortisol reduction in Chandrasekhar et al. (2012) and Langade et al. (2019); NMN's NAD+ elevation in Igarashi et al. (2022). The CD38-cortisol-NAD+ link is supported by mechanistic work but not by a human combination trial.

Assessment: Mechanistically coherent; not directly tested. A reasonable combination for someone managing chronic psychological stress alongside longevity goals. The two compounds have different timing optima — NMN in the morning; ashwagandha at night is common practice based on its sleep-supporting effects.

Stack 5: NMN + Creatine

Mechanistic rationale: Creatine and NMN both support cellular energy availability but through different mechanisms on different timescales. Creatine buffers ATP via the phosphocreatine system — an immediate energy reserve for high-intensity work. NMN supports ATP synthesis efficiency via the electron transport chain and NAD+-dependent metabolic pathways — a structural mitochondrial improvement over weeks. No known antagonism; no shared transport mechanism.

Human evidence: Each has independent evidence: creatine's effects on strength and muscle mass are among the most replicated findings in sports nutrition; Liao et al. (2021) demonstrated aerobic capacity improvements with 300 mg NMN/day over 6 weeks in amateur runners. No combination trial exists.

Assessment: Complementary mechanisms, likely additive for athletes, no known interactions. A practical combination for people prioritizing physical performance alongside metabolic health.

Combinations to Approach Cautiously

• Multiple adaptogens simultaneously: Combining ashwagandha, rhodiola, and eleuthero at full doses risks over-modulating HPA axis signaling. Use one adaptogen at a time; assess effect over 4–6 weeks before considering additions.
• High-dose zinc + magnesium: Both use the DMT1 intestinal transporter and compete for absorption at doses above approximately 25 mg zinc. Take at different times of day if both are in your protocol.
• NMN + niacin (nicotinic acid): Both are NAD+ precursors that enter the same salvage pathway. Combining is redundant for NAD+ purposes. High-dose niacin additionally produces flushing and, at very high doses, can affect liver enzyme levels.
• Fish oil + prescription blood thinners: High-dose omega-3 supplementation has antiplatelet effects and has known interactions with warfarin and antiplatelet medications. This is a drug-supplement interaction requiring prescriber consultation.
• Ashwagandha + thyroid medications: Ashwagandha may modestly increase T3 and T4 levels. In people on thyroid medications, this warrants monitoring and prescriber awareness.

Who Benefits Most From a Stacked Protocol

Supplement stacking makes more practical sense for people with specific, well-defined goals than for general wellness seekers without a defined health target. The longevity supplement stack approach is most defensible when each component has a clear mechanistic target and a defined endpoint.

For those starting out: establish individual supplement response before stacking. Take NMN alone for 6–8 weeks and assess. Add magnesium glycinate. Add ashwagandha if cortisol, sleep, or stress is a specific concern. This staged approach lets you identify what's driving any observed changes, rather than attributing everything to the stack as a whole.

See also NMN and Brain Health for the cognitive rationale behind including NMN specifically in longevity protocols.

Practical Takeaways

• NMN + resveratrol is mechanistically logical but has no published combination human trial; it's hypothesis-driven, not confirmed.
• Magnesium + vitamin D is the most evidence-supported combination: magnesium is required for vitamin D hydroxylation, and vitamin D supplementation increases magnesium demand.
• NMN + TMG may be warranted at high NMN doses (>1000 mg/day) but is likely unnecessary at typical clinical trial doses (250–500 mg/day).
• Avoid combining multiple NAD+ precursors (NMN + niacin + NR) — they enter the same biosynthetic pathway and aren't additive at the NAD+ output level.
• High-dose zinc and magnesium should be taken at separate times if both are in your protocol.
• Introduce supplements one at a time over 6–8 week intervals — this is more informative than starting a full stack at once and losing the ability to attribute changes to a specific compound.

Bottom Line

Most supplement stacking claims outrun the available evidence. A few combinations have genuine mechanistic support and observational human data — magnesium + vitamin D being the clearest example. Others, including NMN + resveratrol, are theoretically sound but remain clinically untested as combinations. Applying the same evidentiary standard to stacks as to individual supplements produces a shorter list of defensible combinations — but a more reliable one. The most important thing isn't having the perfect stack; it's knowing what you're actually adding and why.

References

1. Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224–1229. [Source]
2. Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging. 2022;8(1):5. [Source]
3. Irie J, et al. "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. 2020;67(2):153–160. [Source]
4. Liao B, et al. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners." J Int Soc Sports Nutr. 2021;18(1):54. [Source]
5. Gomes AP, et al. "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging." Cell. 2013;155(7):1624–1638. [Source]
6. Niu KM, et al. "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase." Nutrients. 2023;15(3):755. [Source]

---

---